videos | IST

Hyderabad-based Biological E to manufacture 1 billion doses of COVID-19 vaccines

Biological E, a Hyderabad-based company finds itself in the limelight on the back of the Quad Summit, where leaders from India, the United States, Australia, and Japan decided to join hands in order to bolster vaccine production and supply in the Indo-Pacific region.

Biological E, a Hyderabad-based company finds itself in the limelight on the back of the Quad Summit, where leaders from India, the United States, Australia, and Japan decided to join hands in order to bolster vaccine production and supply in the Indo-Pacific region.
The US government will be providing financial assistance to Biological E to help it manufacture and supply 1 billion COVID vaccine doses in the Indo-Pacific region by 2022. Founded in the year 1953, Biological E was the first private company to begin vaccine manufacturing in India.
CNBC-TV18’s Archana Shukla has more details